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A B S T R A C T
The identiﬁcation and quantiﬁcation of brown adipose tissue (BAT) in adult humans are crucial in current
research efforts targeting BAT in the ﬁght against obesity. Recently, magnetic resonance imaging (MRI)
has shown promise in differentiating BAT from white adipose tissue (WAT) through its ability to depict
relative fat and water content within areas of macroscopic adipose tissue.
We present a case of a 65 year old woman, one of the ﬁrst ever patients scanned on a hybrid posi-
tron emission tomography (PET)/MRI scanner in Australia, in whom extensive physiological BAT uptake
of F-18 ﬂuorodeoxyglucose (FDG) was observed in the supraclavicular fossae that correlated extremely
well with areas of adipose tissue with low fat fraction on MRI.
The ability to reliably and accurately detect and quantify BAT by MRI would eradicate the need for
ionising radiation associated with PET − the current gold standard in imaging of BAT − and have a sig-
niﬁcant positive impact for all human subjects enrolled in BAT studies. More detailed investigation is
required to determine the reproducibility and accuracy of the proposed MRI reconstruction methods for
BAT identiﬁcation in a larger number of subjects.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1 Case report
A 61 year old Caucasian woman presented for restaging of na-
sopharyngeal carcinoma by F-18 ﬂuorodeoxyglucose (FDG) positron
emission tomography (PET)/magnetic resonance imaging (MRI) six
weeks after completion of chemoradiation therapy. PET/MRI was
performed on a commercially available scanner (Siemens Biograph
mMR, Siemens Healthcare, Erlangen, Germany) 70 minutes after in-
travenous administration of 248 MBq of FDG. The PET showed
complete metabolic response of disease, with incidental note of ex-
tensive physiological BAT uptake of FDG in both supraclavicular
fossae. The MRI obtained synchronously with FDG PET included a
two-point T1 Dixon sequence that permitted separation of fat and
water signal through the chemical shift phenomenon [1,2]. We used
a script written with MATLAB (vR2015a, Mathworks, Natick, MA,
USA) on these data to further reconstruct a parametric image dataset
by dividing the fat-only sequence with the in-phase (fat + water)
sequence, thereby obtaining a set of MR images depicting fat frac-
tion that was subsequently displayed on a colour scale and co-
registered with the PET images. Precision of the calculation was
preserved by converting the MR images in sets of 16 bit integer
DICOM images to 32-bit ﬂoating point matrices before perform-
ing the ratio calculation. The images were rescaled before converting
back to a DICOM compliant 16 bit image dataset. The colour scale
(RGB, 8 bits per channel) was then chosen to aid presentation of
the fused data. Interestingly, the areas of lower fat fraction on MRI
correlated extremely well with the areas of increased FDG uptake
on PET – each showing a different characteristic of BAT, namely its
relatively lower fat and higher water content, and its relatively higher
metabolic state compared with white adipose tissue (WAT) (see
Fig. 1).
2 Discussion
There is currently great interest in BAT as a potential target in
the ﬁght against obesity [3]. The accurate detection of BAT in adult
humans represents an important need with scope for optimisation.
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Currently, FDG PET has widespread recognition as the gold stan-
dard for BAT detection and quantiﬁcation, but it necessitates the
use of ionising radiation which can be a signiﬁcant disadvantage
in non-oncology applications.
BAT with low fat content has been shown to be detectable by
MRI in neonates with hypoxic-ischaemic encephalopathy under-
going hypothermia therapy [4], the speculation being that
hypothermia likely promotes BAT-mediated non-shivering thermo-
genesis which subsequently depletes the tissue’s intracellular fat
stores.
Reddy et al. reported the ﬁrst reliable use of MRI to identify BAT
in a living human adult, with histological/immunohistochemical con-
ﬁrmation [5]. In the case report by Reddy et al., a three-point IDEAL
sequence [6] – now a product of General Electric and available on
its MRI scanners – was employed to separate fat and water signal.
More recently, Franz et al. reported the use of a two-point Dixon
sequence similar to the one we used in the present case report, to
derive fat fraction from MRI signal [7]. The Dixon sequence is
common tomost modernMRI scanners’ offerings for fat-water signal
separation. It is a chemical shift imaging method originally pro-
posed in 1984 using two sets of images acquired with slightly
different echo times (TEs) − the ﬁrst with fat and water signals in-
phase and the second with the TE adjusted so that the fat and water
signals are out-of-phase [1,2]. In this way, fat and water signals can
be separated allowing the creation of water-weighted and fat-
weighted images. On fat-weighted images, BAT andWAT both appear
as high signal that is diﬃcult to visually tell apart from each other.
However, by dividing the signal on the fat-weighted sequence with
the in-phase sequence (which by deﬁnition is the sum of water plus
fat signal), parametric images can be produced in which the signal
intensity of the pixels reﬂects tissue fat fraction. In this manner,
highly hydrated BAT with lower fat fraction can be distinguished
from less hydrated WAT which has relatively higher fat fraction.
To the authors’ knowledge, the use of parametric imaging data
reconstructed from the mathematical operation of fat and water
Dixon datasets – and subsequently represented as a colour image
fused with a synchronously acquired FDG PET – has never been re-
ported. However, much work remains to be done to establish the
reproducibility of this technique across a large number of patients
with varying demographic and clinical characteristics. Finally, while
MRI may be useful to quantify the amount of BAT present through
demonstrating the structural difference between BAT and WAT, it
is noteworthy that the presence of BAT does not necessarily cor-
relate with brown fat activation, which depends on the
demonstration of actual glucose consumption achieved with PET.
Infrared thermography represents an alternative to measuring the
actual activity of BAT and has shown promise as a non-ionising ra-
diation, non-invasive and convenient technique for studying BAT
(particularly in the supraclavicular fossae) at different time points
and after various stimuli [8].
Consent
Written informed consent was obtained from the patient for pub-
lication of this case report and accompanying images.
Fig. 1. PET/MRI showing physiological BAT uptake in the supraclavicular fossae. A–D, routine images available with a Dixon sequence. E, parametric MRI data reconstructed
from dividing fat-weighted sequence by in-phase (fat + water) sequence. F–G, FDG PET images. Cross hairs, BAT in the supraclavicular fossae. Red dotted line, axial plane
through which images A–F represent. 3D MIP, three-dimensional maximum intensity projection.
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